Page 127 - 202018
P. 127
from the SSC of the ISTH[J]. J Thromb Haemost，2015，13 et al. Impact of regular physical activity on weekly warfa-
（11）：2119-2126. rin dose requirement[J]. J Thromb Thrombolysis，2015，41
[11] BARNES GD，NALLAMOTHU BK，SALES AE，et al. （2）：328-335.
Reimagining anticoagulation clinics in the era of direct [18] KABALAK PA，SAVAŞ İ，AKAR N，et al. Frequency of
oral anticoagulants[J]. Circ Cardiovasc Qual Outcomes， vitamin K oxidoreductase complex subunit-1（VKORC1）
2016，9（2）：182-185. polymorphisms and warfarin dose management in patients
[12] ELEWA HF，ABDELSAMAD O，ELMUBARK AE，et al. with venous thromboembolism[J]. Pharmacogenomics J，
The first pharmacist-managed anticoagulation clinic under 2018，18（5）：646-651.
a collaborative practice agreement in qatar：clinical and pa- [19] LIANG R，LI L，LI C，et al. Impact of CYP2C9*3，
tient-oriented outcomes[J]. J Clin Pharm Ther，2016，41 VKORC1-1639，CYP4F2 rs2108622 genetic polymor-
（4）：403-408. phism and clinical factors on warfarin maintenance dose
[13] 罗敏，吴斌，吴逢波，等.药师参与抗凝服务对华法林治疗 in Han-Chinese patients[J]. J Thromb Thrombolysis，2012，
管 理 的 效 果 评 价 [J]. 中 国 药 学 杂 志 ，2015，50（6）： 34（1）：120-125.
554-558. [20] TANG W，SHI QP，DING F，et al. Impact of gene poly-
[14] WALLENTIN L，YUSUF S，EZEKOWITZ MD，et al. Ef- morphisms on warfarin maintenance dosage：a novel sys-
ficacy and safety of dabigatran compared with warfarin at temic review and meta-analysis of 53 studies[J]. Int J
different levels of international normalised ratio control Clin Pharmacol Ther，2017，55（4）：304-321.
for stroke prevention in atrial fibrillation：an analysis of [21] CHRISTENSEN TD，LARSEN TB. Precision and accura-
the RE-LY trial[J]. Lancet，2010，376（9745）：975-983. cy of point-of-care testing coagulometers used for
[15] ENTEZARI-MALEKI T，DOUSTI S，HAMISHEHKAR self-testing and self-management of oral anticoagulation
H，et al. A systematic review on comparing two common therapy[J]. J Thromb Haemostasis，2012，10（2）：251-260.
models for management of warfarin therapy；pharma- [22] BARNES GD，KLINE-ROGERS E，GRAVES C，et al.
cist-led service versus usual medical care[J]. J Clin Phar- Structure and function of anticoagulation clinics in the
macol，2015，56（1）：24-38. United States：an AC forum membership survey[J]. J
[16] SPALL HGCV，WALLENTIN L，YUSUF S，et al. Varia- Thromb Thrombolysis，2018，46（1）：7-11.
tion in warfarin dose adjustment practice is responsible [23] VALENCIA D，SPOUTZ P，STOPPI J，et al. Impact of a
for differences in the quality of anticoagulation control be- direct oral anticoagulant population management tool on
tween centers and countries：an analysis of patients receiv- anticoagulation therapy monitoring in clinical practice[J].
ing warfarin in the randomized evaluation of long-term an- Ann Pharmacother，2019，53（8）：806-811.
ticoagulation therapy（RE-LY）trial[J]. Circulation，2012， （收稿日期：2020-05-25 修回日期：2020-08-06）
126（19）：2309-2316. （编辑：陈 宏）
[17] ROULEAU-MAILLOUX É，SHAHABI P，DUMAS S，
《中国药房》杂志——《化学文摘》（CA）收录期刊，欢迎投稿、订阅
中国药房 2020年第31卷第18期 China Pharmacy 2020 Vol. 31 No. 18 ·2293 ·
